According to the new market research study on “Gastrointestinal Drugs Market Forecast to 2027 COVID-19 Impact and Global Analysis by Drug Class, Route of Administration, Application, and Distribution Channel” the market is expected to reach US$ 71,300.28 million in 2027 from US$ 49,043.38 million in 2019. The market is estimated to grow at a CAGR of 4.9% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.
Based on drug class, the market is segmented in to acid neutralizers, antidiarrheal and laxatives, anti-inflammatory drugs, antiemetic and antinauseants, biologics, and others.
In 2019, the acid neutralizers segment held the largest share of the market. The biologics segment is expected to grow at the fastest CAGR during the forecast period. The advent of biologics has had a significant impact on the management of inflammatory bowel disease (IBD). Treatment with biologics has led to an improved quality of life for patients living with Crohn's disease and ulcerative colitis, with fewer admissions to the hospital and less side effects from corticosteroids. These are the most recently developed treatments for IBD. Biologic therapies are indicated for people with moderately to severely active disease who have not responded well to conventional therapy. Four of these agents (adalimumab, certolizumab pegol, golimumab and infliximab) target an inflammatory protein called tumor necrosis factor (TNF). Natalizumab and vedolizumab work by blocking certain types of white blood cells from getting into inflamed tissues.
Biologics are beneficial for patients with gastrointestinal disorders who are not responding to conventional treatment. For instance, infliximab, which is derived from monoclonal antibodies to tumor necrosis factor is another modifier of the immune system's actions. Infliximab is given as a series of infusions by vein. This drug can be given to treat moderate to severe Crohn’s disease that has not responded to other drugs, to treat people with fistulas, and to maintain response when the disease is difficult to control. Vedolizumab and natalizumab are drugs for people who have moderate to severe Crohn’s diseasethat have not responded to TNF inhibitors or other immunomodulating drugs. With the increasing number of biologics in pipeline, the segment is expected to grow at a rapid pace during the forecast period. For instance, Takeda Pharmaceutical Company Limited has five candidates in different phases for various GI indications.
Sanofi; GlaxoSmithKline plc; Johnson and Johnson Services, Inc.; Bausch Health; AstraZeneca; Takeda Pharmaceutical Company Limited; AbbVie Inc.; Bayer AG; Celltrion Healthcare Co. , Ltd; and LEXICON PHARMACEUTICALS, INC. are among the leading companies operating in the gastrointestinal drugs market.
The report segments global gastrointestinal drugs market as follows:
By Drug Class
By Route of Administration
By Application
By Distribution Channel
By Geography
North America
Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)
South and Central America (SCAM)
Reasons to Buy
Based on drug class, the market is segmented in to acid neutralizers, antidiarrheal and laxatives, anti-inflammatory drugs, antiemetic and antinauseants, biologics, and others.
In 2019, the acid neutralizers segment held the largest share of the market. The biologics segment is expected to grow at the fastest CAGR during the forecast period. The advent of biologics has had a significant impact on the management of inflammatory bowel disease (IBD). Treatment with biologics has led to an improved quality of life for patients living with Crohn's disease and ulcerative colitis, with fewer admissions to the hospital and less side effects from corticosteroids. These are the most recently developed treatments for IBD. Biologic therapies are indicated for people with moderately to severely active disease who have not responded well to conventional therapy. Four of these agents (adalimumab, certolizumab pegol, golimumab and infliximab) target an inflammatory protein called tumor necrosis factor (TNF). Natalizumab and vedolizumab work by blocking certain types of white blood cells from getting into inflamed tissues.
Biologics are beneficial for patients with gastrointestinal disorders who are not responding to conventional treatment. For instance, infliximab, which is derived from monoclonal antibodies to tumor necrosis factor is another modifier of the immune system's actions. Infliximab is given as a series of infusions by vein. This drug can be given to treat moderate to severe Crohn’s disease that has not responded to other drugs, to treat people with fistulas, and to maintain response when the disease is difficult to control. Vedolizumab and natalizumab are drugs for people who have moderate to severe Crohn’s diseasethat have not responded to TNF inhibitors or other immunomodulating drugs. With the increasing number of biologics in pipeline, the segment is expected to grow at a rapid pace during the forecast period. For instance, Takeda Pharmaceutical Company Limited has five candidates in different phases for various GI indications.
Sanofi; GlaxoSmithKline plc; Johnson and Johnson Services, Inc.; Bausch Health; AstraZeneca; Takeda Pharmaceutical Company Limited; AbbVie Inc.; Bayer AG; Celltrion Healthcare Co. , Ltd; and LEXICON PHARMACEUTICALS, INC. are among the leading companies operating in the gastrointestinal drugs market.
The report segments global gastrointestinal drugs market as follows:
By Drug Class
- Acid Neutralizers
- Antidiarrheal and Laxatives
- Anti-Inflammatory Drugs
- Antiemetic and Antinauseants
- Biologics
- Others
By Route of Administration
- Oral
- Parenteral
By Application
- Inflammatory Ulcerative Colitis
- Crohn's Disease
- Irritable Bowel Syndrome
- Gastroenteritis
- Celiac Disease
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of APAC
Middle East & Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the gastrointestinal drugs market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global gastrointestinal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Gastrointestinal Drugs Market - By Drug Class
1.3.2 Gastrointestinal Drugs Market - By Route of Administration
1.3.3 Gastrointestinal Drugs Market - By Application
1.3.4 Gastrointestinal Drugs Market - By Distribution Channel
1.3.5 Global Gastrointestinal Drugs Market - By Geography
2. Gastrointestinal Drugs Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Gastrointestinal Drugs- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. Gastrointestinal Drugs Market- Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal (GI) Diseases
5.1.2 Increase in Development of Biologics
5.2 Market Restraints
5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies
5.3 Market Opportunities
5.3.1 Increasing Investment in Research Activities and Growing Pipeline of GI Candidates
5.4 Future Trends
5.4.1 Emergence of Biosimilars
5.5 Impact Analysis
6. Gastrointestinal Drugs Market - Global Analysis
6.1 Global Gastrointestinal Drugs Marker Revenue Forecast And Analysis
6.2 Global Gastrointestinal Drugs Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Gastrointestinal Drugs Market Analysis - By Drug Class
7.1 Overview
7.2 Gastrointestinal Drugs Market Revenue Share, by Drug Class (2019 and 2027)
7.3 Acid Neutralizers
7.3.1 Overview
7.3.2 Acid Neutralizers: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Antidiarrheal and Laxatives
7.4.1 Overview
7.4.2 Antidiarrheal and Laxatives: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Anti-Inflammatory Drugs
7.5.1 Overview
7.5.2 Anti-Inflammatory Drugs: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Antiemetic and Antinauseants
7.6.1 Overview
7.6.2 Antiemetic and Antinauseants: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Biologics
7.7.1 Overview
7.7.2 Biologics: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
8. Gastrointestinal Drugs Market Analysis - By Route of Administration
8.1 Overview
8.2 Gastrointestinal Drugs Market Share, by Route of Administration, 2019 and 2027
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9. Gastrointestinal Drugs Market Analysis - By Application
9.1 Overview
9.2 Gastrointestinal Drugs Market Revenue Share, by Application (2019 and 2027)
9.3 Inflammatory Ulcerative Colitis
9.3.1 Overview
9.3.2 Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Crohn's Disease
9.4.1 Overview
9.4.2 Crohn's Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Irritable Bowel Syndrome
9.5.1 Overview
9.5.2 Irritable Bowel Syndrome: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Gastroenteritis
9.6.1 Overview
9.6.2 Gastroenteritis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Celiac Disease
9.7.1 Overview
9.7.2 Celiac Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
10. Gastrointestinal Drugs Market Analysis - By Distribution Channel
10.1 Overview
10.2 Gastrointestinal Drugs Market Share, by Distribution Channel, 2019 and 2027
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 Hospital Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 Retail Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
10.5 Online Pharmacies
10.5.1 Overview
10.5.2 Online Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
11. Gastrointestinal Drugs Market Analysis And Forecast To 2027 - Geographical Analysis
11.1 North America: Gastrointestinal Drugs Market
11.1.1 Overview
11.1.2 North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.4 North America: Gastrointestinal Drugs Market, by Route of Administration, 2018-2027 (USD Million)
11.1.5 North America: Gastrointestinal Drugs Market, by Application, 2018-2027 (USD Million)
11.1.6 North America: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.7 North America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
11.1.8 US: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.8.3 US: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.8.4 US: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.8.5 US: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.9 Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.9.3 Canada: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.9.4 Canada: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.9.5 Canada: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.10 Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.10.3 Mexico: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.10.4 Mexico: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.10.5 Mexico: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2 Europe: Gastrointestinal Drugs Market
11.2.1 Overview
11.2.2 Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.4 Europe: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.5 Europe: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.6 Europe: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.7 Europe: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
11.2.8 Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.8.3 Germany: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.8.4 Germany: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.8.5 Germany: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.9 UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.9.1 UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.9.2 UK: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.9.3 UK: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.9.4 UK: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.9.5 UK: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.10 France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.10.1 France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.10.2 France: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.10.3 France: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.10.4 France: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.10.5 France: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.11 Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Spain: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.11.3 Spain: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.11.4 Spain: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.11.5 Spain: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.12 Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.1 Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.2 Italy: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.12.3 Italy: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.12.4 Italy: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.12.5 Italy: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.13 Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.13.1 Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.13.2 Rest of Europe: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.13.3 Rest of Europe: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.13.4 Rest of Europe: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.13.5 Rest of Europe: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3 Asia Pacific: Gastrointestinal Drugs Market
11.3.1 Overview
11.3.2 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.4 Asia Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.5 Asia Pacific: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.6 Asia Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.7 Asia Pacific: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
11.3.8 China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.8.3 China: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.8.4 China: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.8.5 China: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.9 Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.9.3 Japan: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.9.4 Japan: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.9.5 Japan: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.10 India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.1 India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.2 India: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.10.3 India: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.10.4 India: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.10.5 India: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.11 South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.1 South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.2 South Korea: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.11.3 South Korea: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.11.4 South Korea: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.11.5 South Korea: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.12 Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.1 Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.2 Australia: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.12.3 Australia: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.12.4 Australia: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.12.5 Australia: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.13 Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.13.1 Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.13.2 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.13.3 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.13.4 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.13.5 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.4 Middle East & Africa: Gastrointestinal Drugs Market
11.4.1 Overview
11.4.2 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
11.4.2.1 Middle East & Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.4.2.2 Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.4.2.3 Middle East & Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.4.2.4 Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.4.3 Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
11.4.3.1 Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.4.3.1.1 Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.4.3.2 Saudi Arabia Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.4.3.3 Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.4.3.4 Saudi Arabia Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.4.3.5 Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.4.3.6 UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.4.3.6.1 UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.4.3.7 UAE Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.4.3.8 UAE Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.4.3.9 UAE Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.4.3.10 UAE Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.5 South Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
11.5.1 South Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)
11.5.1.1 South Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.5.1.2 South Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.5.1.3 South Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.5.1.4 South Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.6 Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
11.6.1 Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)
11.6.1.1 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.6.1.2 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.6.1.3 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.6.1.4 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.7 South and Central America: Gastrointestinal Drugs Market
11.7.1 Overview
11.7.2 South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.3 South and Central America: Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.7.4 South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.7.5 South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.7.6 South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.7.7 South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
11.7.8 Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.8.1 Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.8.2 Brazil: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
11.7.8.3 Brazil: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.7.8.4 Brazil: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.7.8.5 Brazil: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.7.9 Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.9.1 Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.9.2 Argentina: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
11.7.9.3 Argentina: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.7.9.4 Argentina: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.7.9.5 Argentina: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.7.10 Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.10.1 Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.10.2 Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
11.7.10.3 Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.7.10.4 Rest of South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.7.10.5 Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
12. Impact of COVID-19 Pandemic on Global Gastrointestinal Drugs Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
13. Gastrointestinal Drugs Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 Sanofi
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GlaxoSmithKline plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Johnson and Johnson Services, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Bausch Health
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 AstraZeneca
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Takeda Pharmaceutical Company Limited
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AbbVie Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Bayer AG
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Celltrion Healthcare Co.,Ltd.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 LEXICON PHARMACEUTICALS, INC
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 Glossary of TermsList of Tables
Table 1. North America Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 3. North America Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 4. North America Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 5. US Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 6. US Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 7. US Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 8. US Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. Europe Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 18. Europe Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 19. Europe Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. Europe Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 21. Germany Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 22. Germany Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 23. Germany Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 24. Germany Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 25. UK Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 26. UK Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 27. UK Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 28. UK Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 29. France Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 30. France Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 31. France Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 32. France Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 33. Spain Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 34. Spain Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 35. Spain Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 36. Spain Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 37. Italy Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 38. Italy Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 39. Italy Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 40. Italy Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 41. Rest of Europe Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 42. Rest of Europe Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 43. Rest of Europe Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 44. Rest of Europe Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 45. Asia Pacific Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 46. Asia Pacific Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 47. Asia Pacific Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 48. Asia Pacific Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 49. China Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 50. China Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 51. China Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 52. China Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 53. Japan Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 54. Japan Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 55. Japan Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 56. Japan Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 57. India Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 58. India Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 59. India Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 60. India Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 61. South Korea Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 62. South Korea Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 63. South Korea Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 64. South Korea Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 65. Australia Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 66. Australia Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 67. Australia Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 68. Australia Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 69. Rest of Asia -Pacific Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 70. Rest of Asia -Pacific Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 71. Rest of Asia -Pacific Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 72. Rest of Asia -Pacific Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 73. Middle East & Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 74. Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 75. Middle East & Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 76. Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 77. Saudi Arabia Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 78. Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 79. Saudi Arabia Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 80. Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 81. UAE Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 82. UAE Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 83. UAE Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 84. UAE Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 85. South Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 86. South Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 87. South Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 88. South Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 89. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 90. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 91. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 92. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 93. South and Central America: Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 94. South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 95. South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 96. South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 97. Brazil: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
Table 98. Brazil: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 99. Brazil: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 100. Brazil: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 101. Argentina: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
Table 102. Argentina: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 103. Argentina: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 104. Argentina: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 105. Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
Table 106. Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 107. Rest of South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 108. Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic Developments Done By Companies
Table 112. Glossary of Terms, Gastrointestinal Drugs MarketList of Figures
Figure 1. Gastrointestinal Drugs Market Segmentation
Figure 2. Gastrointestinal Drugs Market - by Geography
Figure 3. Gastrointestinal Drugs Market Overview
Figure 4. Acid Neutralizers Segment Held Largest Share of Gastrointestinal Drugs Market
Figure 5. Asia Pacific to show Significant Growth during Forecast Period
Figure 6. Gastrointestinal Drugs Market, by Geography (US$ Million)
Figure 7. Global Gastrointestinal Drugs Market - Leading Country Markets (US$ Million)
Figure 8. Global Gastrointestinal Drugs Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint
Figure 15. Global Gastrointestinal Drugs Market - Revenue Forecast and Analysis - 2019- 2027
Figure 16. Global Gastrointestinal Drugs Market - by Geography Forecast and Analysis - 2019- 2027
Figure 17. Market Positioning of Key Players in Global Gastrointestinal Drugs Market
Figure 18. Gastrointestinal Drugs Market Revenue Share, by Drug Class (2019 and 2027)
Figure 19. Acid Neutralizers: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Antidiarrheal and Laxatives: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Anti-Inflammatory Drugs: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Antiemetic and Antinauseants: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Biologics: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Gastrointestinal Drugs Market Share, by Route of Administration, 2019 and 2027
Figure 26. Oral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Parenteral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Gastrointestinal Drugs Market Revenue Share, by Application (2019 and 2027)
Figure 29. Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Crohn's Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Irritable Bowel Syndrome: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Gastroenteritis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. Celiac Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 34. Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 35. Gastrointestinal Drugs Market Share, by Distribution Channel, 2019 and 2027
Figure 36. Hospital Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 37. Retail Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 38. Online Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
Figure 39. North America: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 40. North America Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 41. North America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
Figure 42. US: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Europe: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 46. Europe Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 47. Europe: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
Figure 48. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 49. UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 50. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. Asia Pacific: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 55. Asia Pacific Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 56. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 57. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 58. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 62. Middle East & Africa: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 63. Middle East & Africa Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 64. Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
Figure 65. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 66. UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 67. South Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)
Figure 68. Rest of Middle East and Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)
Figure 69. South and Central America: Gastrointestinal Drugs Market , by Key Country - Revenue (2019) (USD Million)
Figure 70. South and Central America: Gastrointestinal Drugs Market, Revenue and Forecast to 2027 (USD Million)
Figure 71. South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
Figure 72. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 73. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 74. Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 75. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in North American Countries
Figure 76. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in European Countries
Figure 77. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Asia Pacific Countries
Figure 78. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Rest of the World
Figure 79. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Sanofi
- GlaxoSmithKline plc
- Johnson and Johnson Services, Inc.
- Bausch Health
- AstraZeneca
- Takeda Pharmaceutical Company Limited
- AbbVie Inc.
- Bayer AG
- Celltrion Healthcare Co.,Ltd
- Lexicon Pharmaceuticals, Inc
